2024 annual financial data
Immix Biopharma 2024 Financial results
Direct answer
Revenue was 0 USD.
Operating income was -22,674,680 USD and net income was -21,613,376 USD.
Operating cash flow was -14,595,102 USD.
Get free Immix Biopharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -22,674,680 USD
- Net income
- -21,613,376 USD
- Operating cash flow
- -14,595,102 USD
Explore related company data
View all 2024 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Net marginView Operating cash flow marginView all Immix Biopharma financial years